Raumedic is a trusted partner in the international medical technology and pharmaceutical industry. The medical division of the global corporation REHAU, a family-owned company, has over 70 years of tried and trusted experience in extrusion, injection molding and assembly. With a focus on developing and manufacturing components for a diverse range of diagnostic and therapeutic…
Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies in which body cells are used to heal or support the individual patient. These cells are manipulated or edited to change certain biological characteristics before being transferred to the patient. Personalized medicine is truly about…
MES for Flexible, Paperless Pharmaceutical Production
All companies in the pharmaceutical industry are under pressure for time, quality, compliance, and innovation. These pressures create imperatives to be both paperless and flexible to protect profitability. The stresses and imperatives apply to small-molecule pharmaceuticals, active ingredients (API), contract drug manufacturers (CDMOs), large-molecule biotechnology, and gene and cell therapy makers. Fortunately, a manufacturing execution…
Pave the way to high productivity with continuous manufacturing for pharma
Continuous manufacturing in the pharmaceutical industry is increasing as more manufacturers realize the benefits of the technology. But no two manufacturers are the same, which is why support from the Siemens Smart Manufacturing Solution for Pharmaceuticals helps advance the strategies of your operations. Learn how a pharmaceutical product that previously took 1-2 months in production…
Revolutionizing Pharma Sustainability: Grundfos Solutions for Optimizing Efficiency
This white paper highlights the pressing need for sustainability in the pharmaceutical industry, where energy-intensive processes contribute significantly to environmental impact. Grundfos offers innovative solutions for energy-efficient pumping systems, addressing outdated technology and controls. Readers will learn about the benefits of optimizing pumps, embracing smart technology, benchmarking energy efficiency, and adopting holistic approaches. By implementing…
The Evolution of Heat Sealing
by Charles H. Trillich / Co-Founder Packworld USA Heat sealing technology has evolved over many decades to reduce cost and increase profit with precision heat sealing. This article reflects on these advancements and how to obtain perfect seals every time. In recent years the methods and means of cutting and/or sealing plastic films and joining…
Difficult transmembrane protein targets for therapeutic antibodies
What is the current landscape of antibodies targeting membrane proteins? As of June 2022, 162 antibodies had been approved for a wide array of diseases in the world, including cancers, immune-related diseases, infectious diseases, and hematological diseases1. Over half target membrane proteins, primarily proteins with large extracellular domains and simple transmembrane domains such as tyrosine…
Validatable Band Sealers for Medical Pouches
By Lynn Miranda, Sales Manager for All Packaging Machinery Corp, Ronkonkoma, NY. The customer’s level of confidence and trust is everything. This especially occurs when supplying pouch-sealing machinery for the medical and pharmaceutical industry. I have been taught to evaluate the application and discuss the features of the validation medical pouch-sealing machinery side-by-side to the…
A new way to access scientific papers?
Losing university access doesn’t mean losing access to articles anymore By DeepDyve Digital Library Team Many researchers are surprised to find that leaving university also means leaving behind something they didn’t expect—easy access to peer-reviewed literature. Especially for those who have gone to work at startups or other smaller organizations, finding a way to do…
Anti-idiotype Antibodies: A Powerful Weapon for PK/ADA Assays
By Sino Biological Therapeutic monoclonal antibodies have emerged as the fastest-growing class of therapeutics since the mid-1980s from the increasing number of pharmaceutical companies seeking more drug modalities to extend their pipelines. Additionally, biosimilars now have more opportunities to enter the market as patents of some blockbuster monoclonal antibodies begin to expire. Given this context,…